Regulatory T cells in AKI

Journal of the American Society of Nephrology

Volumn 24, Issue 11, 2013, Pages 1720-1726

  Kinsey, Gilbert R ^a   Sharma, Rahul ^a   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; ATL 1222; BEE VENOM; DIMETHYLSPHINGOSINE; FINGOLIMOD; GARDIQUIMOD; INTERLEUKIN 2; PHOSPHOTRANSFERASE INHIBITOR; PRAVASTATIN; PROBIOTIC AGENT; RAPAMYCIN; RETINOIC ACID; SIMVASTATIN; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ADOPTIVE TRANSFER; ARTICLE; CELL INFILTRATION; CELL MIGRATION; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LEUKOCYTE ACTIVATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; REPERFUSION INJURY;

EID: 84887077445     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013050502     Document Type: Article

References (69)

1. Liangos O, Wald R, O'Bell JW, Price L, Pereira B.J., Jaber BL: Epidemiology and outcomes of acute renal failure in hospitalized patients: A national survey. Clin J Am Soc Nephrol 1: 43-51, 2006
2. Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 380: 756-766, 2012
3. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011
4. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336, 2003 (Pubitemid 36432314)
5. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003 (Pubitemid 36222930)
6. Khattri R, Cox T, Yasayko S.A., Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342, 2003 (Pubitemid 36432315)
7. Shevach EM: Biological functions of regulatory T cells. Adv Immunol 112: 137-176, 2011
8. Chen W, Jin W, Hardegen N., Lei KJ, Li L, Marinos N, McGrady G., Wahl SM: Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886, 2003 (Pubitemid 38032120)
9. Tran DQ, Glass DD, Uzel G, Darnell D.A., Spalding C., Holland SM, Shevach EM: Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol 182: 2929-2938, 2009
10. Liang B, Workman C, Lee J., Chew C, Dale BM, Colonna L, Flores M., Li N, Schweighoffer E, Greenberg S., Tybulewicz V, Vignali D, Clynes R: Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 180: 5916-5926, 2008
11. Sarris M, Andersen KG, Randow F, Mayr L., Betz AG: Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28: 402-413, 2008
12. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T., Miyara M, Fehervari Z, Nomura T., Sakaguchi S: CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275, 2008
13. Yu X, Harden K, Gonzalez L.C., Francesco M., Chiang E, Irving B, Tom I., Ivelja S, Refino CJ, Clark H, Eaton D., Grogan JL: The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 10: 48-57, 2009
14. Deaglio S, Dwyer KM, Gao W, Friedman D., Usheva A, Erat A, Chen J.F., Enjyoji K., Linden J, Oukka M, Kuchroo V.K., Strom TB, Robson SC: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265, 2007 (Pubitemid 46919862)
15. Eltzschig HK, Sitkovsky MV, Robson SC: Purinergic signaling during inflammation. N Engl J Med 367: 2322-2333, 2012
16. Baatar D, Olkhanud P, Sumitomo K., Taub D, Gress R, Biragyn A: Human peripheral blood Tregulatorycells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4-Tregs, regulate effector T cells using FasL. J Immunol 178: 4891-4900, 2007 (Pubitemid 46595271)
17. Gondek DC, Lu LF, Quezada S.A., Sakaguchi S., Noelle RJ: Cutting edge: Contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174: 1783-1786, 2005 (Pubitemid 40223916)
18. Pandiyan P, Zheng L, Ishihara S., Reed J, Lenardo MJ: CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8: 1353-1362, 2007 (Pubitemid 350131172)
19. Shevach EM: Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645, 2009
20. Huehn J, Siegmund K, Lehmann J.C., Siewert C., Haubold U, Feuerer M, Debes G.F., Lauber J., Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Bräuer R, Buer J, Scheffold A, Hamann A: Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 199: 303-313, 2004 (Pubitemid 38252043)
21. Maganto-García E, Bu DX, Tarrio ML, Alcaide P, Newton G, Griffin GK, Croce KJ, Luscinskas FW, Lichtman AH, Grabie N: Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J Immunol 187: 3521-3529, 2011
22. Ring S, Schäfer SC, Mahnke K., Lehr HA, Enk AH: CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 36: 2981-2992, 2006 (Pubitemid 44782572)
23. Bodor J, Bopp T, Vaeth M., Klein M, Serfling E, Hünig T, Becker C., Schild H, Schmitt E: Cyclic AMP underpins suppression by regulatory T cells. Eur J Immunol 42: 1375-1384, 2012
24. Kinsey GR, Sharma R, Huang L., Li L, Vergis AL, Ye H, Ju S.T., Okusa MD: Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20: 1744-1753, 2009
25. Couper KN, Blount DG, de Souza JB, Suffia I, Belkaid Y, Riley EM: Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol 178: 4136-4146, 2007 (Pubitemid 46492363)
26. Lee H, Nho D, Chung H.S., Lee H., Shin MK, Kim SH, Bae H: CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. Kidney Int 78: 1100-1109, 2010
27. Lee SY, Lee YS, Choi H.M., Ko YS, Lee HY, Jo SK, Cho W.Y., Kim HK: Distinct pathophysiologic mechanisms of septic acute kidney injury: Role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 40: 2997-3006, 2012
28. Bonventre JV: Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11: 43-48, 2002 (Pubitemid 34053337)
29. Park KM, Chen A, Bonventre JV: Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 276: 11870-11876, 2001
30. Grenz A, Osswald H, Eckle T., Yang D, Zhang H, Tran Z.V., Klingel K., Ravid K, Eltzschig HK: The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 5: e137, 2008
31. Cho WY, Choi HM, Lee S.Y., Kim MG, Kim HK, Jo SK: The role of Tregs and CD11c(+) macrophages/dendritic cells in ischemic preconditioning of the kidney. Kidney Int 78: 981-992, 2010
32. Kinsey GR, Huang L, Vergis A.L., Li L., Okusa MD: Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 77: 771-780, 2010
33. Gandolfo MT, Jang HR, Bagnasco S.M., Ko GJ, Agreda P, Satpute SR, Crow M.T., King LS, Rabb H: Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729, 2009
34. Monteiro RMM, Camara NOS, Rodrigues MM, Tzelepis F, Damião MJ, Cenedeze M.A., Teixeira VP, dos Reis MA, Pacheco-Silva A: A role for regulatory T cells in renal acute kidney injury. Transpl Immunol 21: 50-55, 2009
35. Gandolfo MT, Jang HR, Bagnasco S.M., Ko GJ, Agreda P, Soloski MJ, Crow M.T., Rabb H: Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. Transpl Immunol 23: 45-52, 2010
36. Brunstein CG, Miller JS, Cao Q, McKenna D.H., Hippen KL, Curtsinger J, Defor T, Levine B.L., June CH, Rubinstein P, McGlave PB, Blazar B.R., Wagner JE: Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 117: 1061-1070, 2011
37. Kinsey GR, Huang L, Jaworska K., Khutsishvili K, Becker DA, Ye H, Lobo P.I., Okusa MD: Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol 23: 1528-1537, 2012
38. Cicora F, Roberti J, Lausada N., González P, Guerrieri D., Stringa P, Raimondi C: Immunosuppression in kidney donors with rapamycin and tacrolimus. Proinflammatory cytokine expression. Medicina (B Aires) 72: 3-9, 2012
39. Mucida D, Park Y, Kim G., Turovskaya O, Scott I, Kronenberg M., Cheroutre H: Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260, 2007 (Pubitemid 47076203)
40. Long SA, Rieck M, Sanda S., Bollyky JB, Samuels PL, Goland R, Ahmann A., Rabinovitch A, Aggarwal S, Phippard D., Turka LA, Ehlers MR, Bianchine PJ, Boyle K.D., Adah SA, Bluestone JA, Buckner JH, Greenbaum CJ; Diabetes TrialNet and the Immune Tolerance Network: Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes 61: 2340-2348, 2012
41. Lai L-W, Yong K-C, Lien Y-HH: Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney Int 81: 983-992, 2012
42. Kim M-G, Lee S.Y., Ko YS, Lee HY, Jo S-K, Cho WY, Kim H-K: CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 26: 111-124, 2011
43. Kim H, Lee G, Park S., Chung H-S, Lee H, Kim J-Y, Nam S, Kim S.K., Bae H: Bee venom mitigates cisplatin-induced nephrotoxicity by regulating CD4(+)CD25(+)Foxp3(+) regulatory T cells in mice. Evid Based Complement Alternat Med 2013: 879845, 2013
44. Hu J, Zhang L, Wang N., Ding R, Cui S, Zhu F., Xie Y, Sun X, Wu D., Hong Q, Li Q, Shi S., Liu X, Chen X: Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int 84: 521-531, 2013
45. Kim MG, Koo TY, Yan J.J., Lee E., Han KH, Jeong JC, Ro H, Kim B.S., Jo SK, Oh KH, Surh CD, Ahn C, Yang J: IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury throughexpansion of regulatory Tcells. J Am Soc Nephrol 24: 1529-1536, 2013
46. Kleinschnitz C, Kraft P, Dreykluft A., Hagedorn I, Göbel K, Schuhmann M.K., Langhauser F., Helluy X, Schwarz T, Bittner S., Mayer CT, Brede M, Varallyay C, Pham M., Bendszus M, Jakob P, Magnus T., Meuth SG, Iwakura Y, Zernecke A, Sparwasser T., Nieswandt B, Stoll G, Wiendl H: Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 121: 679-691, 2013
47. Liesz A, Suri-Payer E, Veltkamp C., Doerr H, Sommer C, Rivest S., Giese T, Veltkamp R: Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15: 192-199, 2009
48. Ren X, Akiyoshi K, Vandenbark A.A., Hurn PD, Offner H: CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis 26: 87-90, 2011
49. Dobaczewski M, Xia Y, Bujak M., Gonzalez-Quesada C, Frangogiannis NG: CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol 176: 2177-2187, 2010
50. Ke D, Fang J, Fan L., Chen Z, Chen L: Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury. Coron Artery Dis 24: 334-341, 2013
51. Devey LR, Richards JA, O'Connor RA, Borthwick G, Clay S., Howie AF, Wigmore SJ, Anderton SM, Howie SE: Ischemic preconditioning in the liver is independent of regulatory T cell activity. PLoS One 7: e49647, 2012
52. Kuboki S, Sakai N, Tschöp J, Edwards M.J., Lentsch AB, Caldwell CC: Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury. Am J Physiol Gastrointest Liver Physiol 296: G1054-G1059, 2009
53. Lu L, Li G, Rao J, Pu L., Yu Y, Wang X, Zhang F: In vitro induced CD4(+)CD25(+)Foxp3(+) Tregs attenuate hepatic ischemia-reperfusion injury. Int Immunopharmacol 9: 549-552, 2009
54. Yang X, Bai H, Wang Y., Li J, Zhou Q, Cai W., Han J, Zhu X, Dong M., Hu D: Deletion of regulatory T cells supports the development of intestinal ischemia-reperfusion injuries. J Surg Res 184: 832-837, 2013
55. Murphy TJ, Ni Choileain N, Zang Y, Mannick J.A., Lederer JA: CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 174: 2957-2963, 2005 (Pubitemid 40279715)
56. Wang YM, Hu M, Wang Y., Polhill T, Zhang GY, Wang Y, Lee V.W., Harris DC, Alexander SI: Regulatory T cells in renal disease. Int J Clin Exp Med 1: 294-304, 2008
57. Mahajan D, Wang Y, Qin X., Wang Y, Zheng G, Wang Y.M., Alexander SI, Harris DC: CD4 +CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 17: 2731-2741, 2006 (Pubitemid 44484663)
58. Wolf D, Hochegger K, Wolf A.M., Rumpold HF, Gastl G, Tilg H, Mayer G., Gunsilius E, Rosenkranz AR: CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16: 1360-1370, 2005 (Pubitemid 41716520)
59. Scalapino KJ, Tang Q, Bluestone J.A., Bonyhadi ML, Daikh DI: Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177: 1451-1459, 2006 (Pubitemid 44092478)
60. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L., Porrett PM, Li B, Turka LA, Olson E.N., Greene MI, Wells AD, Hancock WW: Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13: 1299-1307, 2007 (Pubitemid 350073591)
61. Mausner-Fainberg K., Luboshits G, Mor A., Maysel-Auslender S, Rubinstein A, Keren G., George J: The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25 + T cells. Atherosclerosis 197: 829-839, 2008 (Pubitemid 351417882)
62. Ahmadzadeh M, Rosenberg SA: IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 107: 2409-2414, 2006 (Pubitemid 43345561)
63. Zhang H, Chua KS, Guimond M, Kapoor V., Brown MV, Fleisher TA, Long LM, Bernstein D, Hill B.J., Douek DC, Berzofsky JA, Carter CS, Read E.J., Helman LJ, Mackall CL: Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med 11: 1238-1243, 2005 (Pubitemid 43093672)
64. Webster KE, Walters S, Kohler R.E., Mrkvan T., Boyman O, Surh CD, Grey S.T., Sprent J: In vivo expansion of T reg cells with IL-2-mAb complexes: Induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 206: 751-760, 2009
65. Javeed A, Zhang B, Qu Y., Zhang A, Sun C, Zhang L., Liu J, Zeng C, Zhao Y: The signifi-cantlyenhanced frequency of functional CD4 +CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice. Transpl Immunol 20: 253-260, 2009
66. Kwon HK, Lee CG, So J.S., Chae CS, Hwang JS, Sahoo A, Nam J.H., Rhee JH, Hwang KC, Im SH: Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107: 2159-2164, 2010
67. Schreiber TH, Wolf D, Tsai M.S., Chirinos J., Deyev VV, Gonzalez L, Malek TR, Levy R.B., Podack ER: Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J Clin Invest 120: 3629-3640, 2010
68. Caramalho I, Lopes-Carvalho T, Ostler D., Zelenay S, Haury M, Demengeot J: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197: 403-411, 2003 (Pubitemid 36278597)
69. Forward NA, Furlong SJ, Yang Y, Lin T.J., Hoskin DW: Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells. J Leukoc Biol 87: 117-125, 2010